关于
  • English
  • About
    • Management
    • Board of Directors
    • Strategic Advisory Board
    • Our Partners
    • Proprietary Platform Technology
    • About TFChem
  • Programs
    • Pipeline
      • Antiviral
    • Skincare – Dark Spot Correction
    • Skincare – GlycoProteMim™
  • News
    • Sirona News
    • Events
  • Investors
    • Financial Information
    • Financial Reports
    • Investor & Media Kit
    • Newsletter
    • AGM
  • Contact
  • Careers

September 26th, 2018

Sirona Biochem Receives Positive Safety Data for Lead Skin-Lightener in Preparation for Clinical Trial in the US

August 28th, 2018

Sirona Biochem Receives $500,000 USD Milestone Payment from Wanbang Biopharmaceuticals

July 12th, 2018

Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial

April 30th, 2018

Sirona Biochem to Exhibit at the Shanghai China Beauty Expo 2018

February 2nd, 2018

Sirona Biochem Announces Chief Scientific Officer to Present at Adaptations in Polar Environments and Biomimicry

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 30
  • Next Page »

Archives

  • About
  • TFChem
  • Programs
  • News
  • Investors
  • Contact

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
555 Burrard St.
Vancouver, B.C., Canada,V7X1M8

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

© 2025 Sirona Biochem.

Sirona Biochem Corp
c/o WeWork
595 Burrard St.
Vancouver, B.C., Canada,V7X 1L4

TFCHEM
Voie de l’innovation
Pharma Parc II Chaussée du Vexin
27100 Val de Reuil, France

Investor enquires: 604.641.4466
info@sironabiochem.com

Enter your info below to subscribe to our newsletter:
Loading